7 Biggest Mid-Day Losers For Tuesday

Loading...
Loading...

 

  • Regulus Therapeutics Inc RGLS shares dropped 45.6 percent to $2.72 after the FDA said it had placed the company’s lead product candidate, RG-101 for the treatment of hepatitis C virus (HCV) infection, on clinical hold.
  • Celyad SA (ADR) CYAD shares fell 36.5 percent to $26.97. Celyad reported that its CHART-1 Phase 3 trial did not meet primary endpoint.
  • COMSCORE, Inc. SCOR shares fell 21.2 percent to $23.16. COMSCORE has delayed to file its Annual Report on Form 10-K for the year ended December 31, 2015. The company reported that its Audit Committee and Board need further time to evaluate the information collected and make final conclusions.
  • Babcock & Wilcox Enterprises Inc BW declined 21 percent to $15.03 after the company lowered its 2016 earnings forecast and announced plans to cut over 200 positions in North America immediately.
  • Fibrocell Science Inc FCSC shares dropped 12.2 percent to $1.20.
  • Medigus Ltd. MDGS shares fell 12.1 percent to $1.14.
  • Dow Chemical Co DOW shares declined 3.1 percent to $48.00. JP Morgan downgraded Dow Chemical from Overweight to Neutral.
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...